2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$62.61-$0.010 (-0.02%)
Price as of Aug 21, 2026 7:30 PM EDT- $9.3BMarket Cap
- 93.93%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$62.61-$0.010 (-0.02%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $62.62 | ||
Change | +$1.28 (+2.09%) | ||
Open | $61.60 | ||
High | $63.98 | ||
Low | $61.60 | ||
Previous Close | $61.34 | ||
Volume | 1,141,514 | ||
30-Day Average Volume | 966,303 | ||
1-Week Change | 7.84% | ||
1-Month Change | 7.89% | ||
1-Year Change | 93.93% | ||
3-Year Change | 25.97% | ||
5-Year Change | 192.21% | ||
Fundamentals | |||
Shares Outstanding | 148.8M | ||
Total Assets | $3.1B | ||
Market Cap | $9.3B | ||
Enterprise Value | $9.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$284.3M | ||
Free Cash Flow | -$236.8M | ||
EBIT | -$284.3M | ||
EBITDA | -$281.3M | ||
Net Working Capital | $1.3B | ||
EPS | -$1.97 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | -2 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue